Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
Hesham, Heba M; Lasheen, Deena S.; Khaled A M Abouzid;
Abstract
Recently, molecular hybridization paradigm became an interesting and smart way to defeat the multifaceted cancer disease by a single molecular entity that acts via several mechanisms just like a magic bullet. Also, HDAC is an important epigenetic target in drug discovery, and the HDAC inhibitors showed successful pattern as cytotoxic agents. Because of their flexible structure activity relationship, it was easy to link them to other anticancer scaffolds. So, many dual action HDAC inhibitors have been developed and most of these hybrids have higher potency than the constituting parents in fighting of the cancer cells. This review describes potential applications of chimeric HDAC inhibitors, which simultaneously modulate not only HDAC but also multiple targets, in treatment of relapsing and drug-resistant cancers. We have nearly collected most of the reported dual action HDAC inhibitors yet to provide a comprehensive guide for the drug discovery process for developing more efficient anticancer agents.
Other data
Title | Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer | Authors | Hesham, Heba M; Lasheen, Deena S. ; Khaled A M Abouzid | Keywords | molecular hybridization;cancer resistance;cancer stem cell;chimeric anticancer agents;dual action HDAC inhibitors | Issue Date | Sep-2018 | Publisher | WILEY | Journal | Medicinal research reviews | Volume | 38 | Issue | 6 | Start page | 2058 | End page | 2109 | ISSN | 0198-6325 | DOI | 10.1002/med.21505 | PubMed ID | 29733427 | Scopus ID | 2-s2.0-85046425829 | Web of science ID | WOS:000446523000009 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.